Operating Expenses

Amortization of Right-of-Use Assets

Vertex Pharmaceuticals Amortization of Right-of-Use Assets remained flat by 0.0% to $1.80M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 76.7%, from $7.73M to $1.80M. Over 2 years (FY 2023 to FY 2025), Amortization of Right-of-Use Assets shows a downward trend with a -58.9% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.

Analysis

StatementIncome Statement
SectionOperating Expenses
CategoryEfficiency
SignalLower is better
VolatilityStable
First reportedQ1 2023
Last reportedQ4 2025Feb 13, 2026

How to read this metric

Changes reflect the scale of the company's leased asset base and the remaining duration of lease contracts.

Detailed definition

The non-cash expense representing the systematic allocation of the cost of a right-of-use asset over its lease term. Thi...

Peer comparison

Standard accounting metric for companies reporting under ASC 842.

Metric ID: tmusz_amortization_of_rou_assets

Historical Data

3 years
 FY'23FY'24FY'25
Value$42.70M$30.90M$7.20M
YoY Change-27.6%-76.7%
Range$7.20M$42.70M
CAGR-58.9%
Avg YoY Growth-52.2%
Median YoY Growth-52.2%
Current Streak2+ years decline

Amortization of Right-of-Use Assets at Other Companies

Frequently Asked Questions

What is Vertex Pharmaceuticals's amortization of right-of-use assets?
Vertex Pharmaceuticals (VRTX) reported amortization of right-of-use assets of $1.80M in Q4 2025.
How has Vertex Pharmaceuticals's amortization of right-of-use assets changed year-over-year?
Vertex Pharmaceuticals's amortization of right-of-use assets decreased by 76.7% year-over-year, from $7.73M to $1.80M.
What is the long-term trend for Vertex Pharmaceuticals's amortization of right-of-use assets?
Over 2 years (2023 to 2025), Vertex Pharmaceuticals's amortization of right-of-use assets has grown at a -58.9% compound annual growth rate (CAGR), from $42.70M to $7.20M.
What does amortization of right-of-use assets mean?
The periodic expense of using a leased asset.